Jonathan R. Fromm

6.7k total citations · 2 hit papers
103 papers, 4.7k citations indexed

About

Jonathan R. Fromm is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Jonathan R. Fromm has authored 103 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Pathology and Forensic Medicine, 45 papers in Oncology and 24 papers in Immunology. Recurrent topics in Jonathan R. Fromm's work include Lymphoma Diagnosis and Treatment (63 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Jonathan R. Fromm is often cited by papers focused on Lymphoma Diagnosis and Treatment (63 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Jonathan R. Fromm collaborates with scholars based in United States, South Africa and Germany. Jonathan R. Fromm's co-authors include Robert J. Linhardt, Ronald E. Hileman, John M. Weiler, Brent L. Wood, Douglas C. Rees, Salem Faham, Yaping Chen, Rory M. Marks, Terry Maguire and Jeffrey D. Esko and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition.

In The Last Decade

Jonathan R. Fromm

98 papers receiving 4.6k citations

Hit Papers

Dengue virus infectivity depends on envelope protein bind... 1996 2026 2006 2016 1997 1996 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
    1997 841 citations Ronald E. Hileman, Jonathan R. Fromm et al. profile →
  2. Heparin Structure and Interactions with Basic Fibroblast Growth Factor
    1996 673 citations Ronald E. Hileman, Jonathan R. Fromm et al. profile →

Peers

Jonathan R. Fromm
Özden Sanal Türkiye
Marı́a Yáñez-Mó Spain
Linda M. Pilarski Canada
Christof R. Hauck Germany
Akifumi Takaori‐Kondo Japan
Thomas Winkler Germany
Steven R. Tronick United States
Winfried F. Pickl Austria
Geoffrey S. Kansas United States
Óscar R. Burrone Italy
Özden Sanal Türkiye
Jonathan R. Fromm
Citations per year, relative to Jonathan R. Fromm Jonathan R. Fromm (= 1×) peers Özden Sanal

Countries citing papers authored by Jonathan R. Fromm

Since Specialization
Citations

This map shows the geographic impact of Jonathan R. Fromm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan R. Fromm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan R. Fromm more than expected).

Fields of papers citing papers by Jonathan R. Fromm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan R. Fromm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan R. Fromm. The network helps show where Jonathan R. Fromm may publish in the future.

Co-authorship network of co-authors of Jonathan R. Fromm

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan R. Fromm. A scholar is included among the top collaborators of Jonathan R. Fromm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan R. Fromm. Jonathan R. Fromm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oak, Jean, Pedro Horna, Jonathan R. Fromm, et al.. (2025). A practical approach to panel design, validation, and interpretation for the evaluation of T ‐cell neoplasms by flow cytometry. Cytometry Part B Clinical Cytometry. 108(6). 430–447.
2.
Voutsinas, Jenna, Jonathan R. Fromm, Renato Martins, et al.. (2024). Long term outcomes in patients with recurrent/metastatic (R/M) salivary gland cancer (SGC) treated with immune checkpoint inhibitors (ICI).. Journal of Clinical Oncology. 42(16_suppl). e18063–e18063. 1 indexed citations
3.
Cenariu, Diana, Jón Þór Bergþorsson, Ravnit Grewal, et al.. (2023). Flow Cytometry of CD5-Positive Hairy Cell Leukemia. Molecular Diagnosis & Therapy. 27(5). 593–599. 2 indexed citations
4.
Gopal, Ajay K., Brian G. Till, Mazyar Shadman, et al.. (2023). Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up. Clinical Lymphoma Myeloma & Leukemia. 24(2). e33–e39.e1. 5 indexed citations
5.
6.
Chen, Xueyan, Jonathan R. Fromm, & Kikkeri N. Naresh. (2022). “Blasts” in myeloid neoplasms – how do we define blasts and how do we incorporate them into diagnostic schema moving forward?. Leukemia. 36(2). 327–332. 7 indexed citations
7.
Wang, Anlai, Zhili Song, Gang Zheng, et al.. (2021). Evaluation of Preclinical Activity of Isatuximab in Patients with Acute Lymphoblastic Leukemia. Molecular Cancer Therapeutics. 20(10). 1916–1925. 11 indexed citations
8.
Simonson, Paul D., Yue Wu, David Wu, Jonathan R. Fromm, & Aaron Lee. (2021). De Novo Identification and Visualization of Important Cell Populations for Classic Hodgkin Lymphoma Using Flow Cytometry and Machine Learning. American Journal of Clinical Pathology. 156(6). 1092–1102. 13 indexed citations
9.
Lynch, Ryan C., Ryan D. Cassaday, Stephen D. Smith, et al.. (2021). Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study. The Lancet Haematology. 8(8). e562–e571. 33 indexed citations
10.
Cassaday, Ryan D., Jonathan R. Fromm, Mary‐Elizabeth M. Percival, et al.. (2020). Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia. Blood Advances. 4(14). 3239–3245. 19 indexed citations
11.
Rodriguez, Cristina P., Qian Wu, Jenna Voutsinas, et al.. (2019). A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer. Clinical Cancer Research. 26(4). 837–845. 135 indexed citations
12.
Cader, Fathima Zumla, Ron C.J. Schackmann, Xihao Hu, et al.. (2018). Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell–rich and exhausted T-effector microenvironment. Blood. 132(8). 825–836. 111 indexed citations
13.
14.
15.
Wu, David, Brent L. Wood, & Jonathan R. Fromm. (2012). Flow Cytometry for Non-Hodgkin and Classical Hodgkin Lymphoma. Methods in molecular biology. 971. 27–47. 17 indexed citations
16.
Jokinen, Chris H., Jonathan R. Fromm, Zsolt B. Argényi, et al.. (2011). Flow Cytometric Evaluation of Skin Biopsies for Mycosis Fungoides. American Journal of Dermatopathology. 33(5). 483–491. 10 indexed citations
17.
Edlefsen, Kerstin L., et al.. (2011). Early Lymph Node Involvement by Mantle Cell Lymphoma Limited to the Germinal Center. American Journal of Clinical Pathology. 136(2). 276–281. 13 indexed citations
18.
Fromm, Jonathan R.. (2010). Flow cytometric analysis of CD123 is useful for immunophenotyping classical Hodgkin lymphoma. Cytometry Part B Clinical Cytometry. 80B(2). 91–99. 32 indexed citations
19.
Fromm, Jonathan R., Steven J. Kussick, & Brent L. Wood. (2006). Identification and Purification of Classical Hodgkin Cells From Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. American Journal of Clinical Pathology. 126(5). 764–780. 61 indexed citations
20.
Hileman, Ronald E., Jonathan R. Fromm, John M. Weiler, & Robert J. Linhardt. (1998). Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. BioEssays. 20(2). 156–167. 484 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Özden Sanal Breakdown of academic impact, for papers by Marı́a Yáñez-Mó Breakdown of academic impact, for papers by Linda M. Pilarski Breakdown of academic impact, for papers by Christof R. Hauck Breakdown of academic impact, for papers by Akifumi Takaori‐Kondo Breakdown of academic impact, for papers by Thomas Winkler Breakdown of academic impact, for papers by Steven R. Tronick Breakdown of academic impact, for papers by Winfried F. Pickl Breakdown of academic impact, for papers by Geoffrey S. Kansas Breakdown of academic impact, for papers by Óscar R. Burrone
Rankless by CCL
2026